伴有乙状结肠转移的smarca4缺陷非小细胞肺癌1例

IF 2.5 3区 医学 Q3 ONCOLOGY
Rong Xiao, Guang Fu, Xinglan Li, Tao Lu
{"title":"伴有乙状结肠转移的smarca4缺陷非小细胞肺癌1例","authors":"Rong Xiao, Guang Fu, Xinglan Li, Tao Lu","doi":"10.1186/s12957-025-03757-7","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily a, member 4-deficient non-small cell lung cancer (SMARCA4-dNSCLC) is a rare subtype of NSCLC whose definitive radiographic characteristics have not yet been fully delineated. Clinically, these tumors often metastasize to distant organs and lymph nodes at an early stage, which is strongly associated with poor clinical prognosis. The common metastatic sites include bone, brain, adrenal glands, liver, and spleen, whereas intestinal metastasis is extremely rare. In this case, we describe a rare instance of SMARCA4-deficient NSCLC with metastasis to the sigmoid colon.</p><p><strong>Case description: </strong>A 59-year-old male presented with hoarseness and shortness of breath. Computed tomography (CT) imaging revealed an irregular mass in the posterior apical segment of the upper lobe of the left lung, with enlarged lymph nodes in the mediastinum and left lung hilum. A biopsy of the lung mass confirmed the diagnosis of NSCLC with SMARCA4 gene deletion. CT also revealed uneven thickening of the sigmoid colon wall, which was proved to be metastases from the lung cancer through surgical pathology. The patient initially underwent chemotherapy combined with immunotherapy and intensity-modulated radiotherapy for the lungs. However, a follow-up CT revealed progression in the sigmoid colon tumor. Consequently, the patient underwent laparoscopic radical sigmoid colectomy with regional lymph node dissection. Two months postoperatively, metastasis to the left adrenal gland was detected. The treatment regimen was adjusted to a combination therapy consisting of gemcitabine, nedaplatin, bevacizumab, and camrelizumab accordingly. The patient demonstrated a favorable response to this treatment, with no evidence of recurrence or further metastasis to date.</p><p><strong>Conclusions: </strong>This case represents the first reported instance of SMARCA4-dNSCLC with metastasis to the sigmoid colon. The atypical clinical and radiological features of this condition pose significant diagnostic challenges, particularly in differentiating metastatic lesions from primary colonic tumors. This case underscores the significance of recognizing rare metastatic patterns in SMARCA4-dNSCLC, enriching the literature on its diverse manifestations and providing a critical reference for clinicians in diagnosing and managing SMARCA4-dNSCLC with sigmoid colon metastasis.</p>","PeriodicalId":23856,"journal":{"name":"World Journal of Surgical Oncology","volume":"23 1","pages":"106"},"PeriodicalIF":2.5000,"publicationDate":"2025-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11954277/pdf/","citationCount":"0","resultStr":"{\"title\":\"SMARCA4-deficient non-small cell lung cancer with metastasis to the sigmoid colon: a case report.\",\"authors\":\"Rong Xiao, Guang Fu, Xinglan Li, Tao Lu\",\"doi\":\"10.1186/s12957-025-03757-7\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily a, member 4-deficient non-small cell lung cancer (SMARCA4-dNSCLC) is a rare subtype of NSCLC whose definitive radiographic characteristics have not yet been fully delineated. Clinically, these tumors often metastasize to distant organs and lymph nodes at an early stage, which is strongly associated with poor clinical prognosis. The common metastatic sites include bone, brain, adrenal glands, liver, and spleen, whereas intestinal metastasis is extremely rare. In this case, we describe a rare instance of SMARCA4-deficient NSCLC with metastasis to the sigmoid colon.</p><p><strong>Case description: </strong>A 59-year-old male presented with hoarseness and shortness of breath. Computed tomography (CT) imaging revealed an irregular mass in the posterior apical segment of the upper lobe of the left lung, with enlarged lymph nodes in the mediastinum and left lung hilum. A biopsy of the lung mass confirmed the diagnosis of NSCLC with SMARCA4 gene deletion. CT also revealed uneven thickening of the sigmoid colon wall, which was proved to be metastases from the lung cancer through surgical pathology. The patient initially underwent chemotherapy combined with immunotherapy and intensity-modulated radiotherapy for the lungs. However, a follow-up CT revealed progression in the sigmoid colon tumor. Consequently, the patient underwent laparoscopic radical sigmoid colectomy with regional lymph node dissection. Two months postoperatively, metastasis to the left adrenal gland was detected. The treatment regimen was adjusted to a combination therapy consisting of gemcitabine, nedaplatin, bevacizumab, and camrelizumab accordingly. The patient demonstrated a favorable response to this treatment, with no evidence of recurrence or further metastasis to date.</p><p><strong>Conclusions: </strong>This case represents the first reported instance of SMARCA4-dNSCLC with metastasis to the sigmoid colon. The atypical clinical and radiological features of this condition pose significant diagnostic challenges, particularly in differentiating metastatic lesions from primary colonic tumors. This case underscores the significance of recognizing rare metastatic patterns in SMARCA4-dNSCLC, enriching the literature on its diverse manifestations and providing a critical reference for clinicians in diagnosing and managing SMARCA4-dNSCLC with sigmoid colon metastasis.</p>\",\"PeriodicalId\":23856,\"journal\":{\"name\":\"World Journal of Surgical Oncology\",\"volume\":\"23 1\",\"pages\":\"106\"},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2025-03-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11954277/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"World Journal of Surgical Oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1186/s12957-025-03757-7\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Journal of Surgical Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12957-025-03757-7","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:SWI/ snf相关,基质相关,肌动蛋白依赖的染色质调节因子,亚家族a,成员4缺失的非小细胞肺癌(SMARCA4-dNSCLC)是一种罕见的非小细胞肺癌亚型,其明确的放射学特征尚未完全描述。临床上,这些肿瘤常在早期转移到远处器官和淋巴结,这与临床预后不良密切相关。常见的转移部位包括骨、脑、肾上腺、肝脏和脾脏,而肠转移则极为罕见。在本病例中,我们描述了一例罕见的smarca4缺陷非小细胞肺癌转移到乙状结肠的病例。病例描述:一名59岁男性,表现为声音嘶哑和呼吸短促。CT显示左肺上叶后尖段不规则肿块,纵膈及左肺门淋巴结肿大。肺肿块活检证实了伴有SMARCA4基因缺失的NSCLC的诊断。CT显示乙状结肠壁不均匀增厚,经手术病理证实为肺癌转移灶。患者最初接受化疗联合免疫治疗和肺部调强放疗。然而,随访的CT显示乙状结肠肿瘤进展。因此,患者接受了腹腔镜根治性乙状结肠切除术和区域淋巴结清扫术。术后2个月发现左肾上腺转移。治疗方案相应地调整为吉西他滨、奈达铂、贝伐单抗和camrelizumab的联合治疗。患者对这种治疗表现出良好的反应,迄今为止没有复发或进一步转移的证据。结论:该病例是首例伴有乙状结肠转移的SMARCA4-dNSCLC。这种疾病的非典型临床和放射学特征给诊断带来了重大挑战,特别是在鉴别转移性病变和原发性结肠肿瘤时。本病例强调了识别SMARCA4-dNSCLC罕见转移模式的重要性,丰富了其多样化表现的文献,为临床医生诊断和治疗伴有乙状结肠转移的SMARCA4-dNSCLC提供了重要参考。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
SMARCA4-deficient non-small cell lung cancer with metastasis to the sigmoid colon: a case report.

Background: SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily a, member 4-deficient non-small cell lung cancer (SMARCA4-dNSCLC) is a rare subtype of NSCLC whose definitive radiographic characteristics have not yet been fully delineated. Clinically, these tumors often metastasize to distant organs and lymph nodes at an early stage, which is strongly associated with poor clinical prognosis. The common metastatic sites include bone, brain, adrenal glands, liver, and spleen, whereas intestinal metastasis is extremely rare. In this case, we describe a rare instance of SMARCA4-deficient NSCLC with metastasis to the sigmoid colon.

Case description: A 59-year-old male presented with hoarseness and shortness of breath. Computed tomography (CT) imaging revealed an irregular mass in the posterior apical segment of the upper lobe of the left lung, with enlarged lymph nodes in the mediastinum and left lung hilum. A biopsy of the lung mass confirmed the diagnosis of NSCLC with SMARCA4 gene deletion. CT also revealed uneven thickening of the sigmoid colon wall, which was proved to be metastases from the lung cancer through surgical pathology. The patient initially underwent chemotherapy combined with immunotherapy and intensity-modulated radiotherapy for the lungs. However, a follow-up CT revealed progression in the sigmoid colon tumor. Consequently, the patient underwent laparoscopic radical sigmoid colectomy with regional lymph node dissection. Two months postoperatively, metastasis to the left adrenal gland was detected. The treatment regimen was adjusted to a combination therapy consisting of gemcitabine, nedaplatin, bevacizumab, and camrelizumab accordingly. The patient demonstrated a favorable response to this treatment, with no evidence of recurrence or further metastasis to date.

Conclusions: This case represents the first reported instance of SMARCA4-dNSCLC with metastasis to the sigmoid colon. The atypical clinical and radiological features of this condition pose significant diagnostic challenges, particularly in differentiating metastatic lesions from primary colonic tumors. This case underscores the significance of recognizing rare metastatic patterns in SMARCA4-dNSCLC, enriching the literature on its diverse manifestations and providing a critical reference for clinicians in diagnosing and managing SMARCA4-dNSCLC with sigmoid colon metastasis.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
4.70
自引率
15.60%
发文量
362
审稿时长
3 months
期刊介绍: World Journal of Surgical Oncology publishes articles related to surgical oncology and its allied subjects, such as epidemiology, cancer research, biomarkers, prevention, pathology, radiology, cancer treatment, clinical trials, multimodality treatment and molecular biology. Emphasis is placed on original research articles. The journal also publishes significant clinical case reports, as well as balanced and timely reviews on selected topics. Oncology is a multidisciplinary super-speciality of which surgical oncology forms an integral component, especially with solid tumors. Surgical oncologists around the world are involved in research extending from detecting the mechanisms underlying the causation of cancer, to its treatment and prevention. The role of a surgical oncologist extends across the whole continuum of care. With continued developments in diagnosis and treatment, the role of a surgical oncologist is ever-changing. Hence, World Journal of Surgical Oncology aims to keep readers abreast with latest developments that will ultimately influence the work of surgical oncologists.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信